160 related articles for article (PubMed ID: 22386623)
1. Two decades' experience with a prospective biobank for urologic oncology: research, clinical care, and the patients' view.
Huber J; Herpel E; Jakobi H; Hadaschik BA; Pahernik S; Hohenfellner M
Urol Oncol; 2013 Oct; 31(7):990-6. PubMed ID: 22386623
[TBL] [Abstract][Full Text] [Related]
2. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
3. The NCI All Ireland Cancer Conference.
Johnston PG; Daly PA; Liu E
Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
[TBL] [Abstract][Full Text] [Related]
4. Surgeon leadership enables development of a colorectal cancer biorepository.
Tsikitis VL; Lu KC; Douthit M; Herzig DO
Am J Surg; 2013 May; 205(5):563-5; discussion 565. PubMed ID: 23592163
[TBL] [Abstract][Full Text] [Related]
5. Start-up of a clinical sample processing, storage and management platform: organisation and development of the REDinREN Biobank.
Calleros L; Cortés MA; Luengo A; Mora I; Guijarro B; Martín P; Ortiz-Arduán A; Selgas R; Rodríguez-Puyol D; Rodríguez-Puyol M
Nefrologia; 2012; 32(1):28-34. PubMed ID: 22294002
[TBL] [Abstract][Full Text] [Related]
6. [Biobanking: the basis for molecular research in uro-oncology].
López-Beltrán A; Vidal A; Blanca A
Arch Esp Urol; 2013 Jun; 66(5):416-22. PubMed ID: 23793759
[TBL] [Abstract][Full Text] [Related]
7. Down syndrome: issues to consider in a national registry, research database and biobank.
McCabe LL; McCabe ER
Mol Genet Metab; 2011; 104(1-2):10-2. PubMed ID: 21501965
[TBL] [Abstract][Full Text] [Related]
8. [The Nice CHU biobank experience to collect patients' informed consent for research context (2004-2009)].
Hofman V; Bonnetaud C; Gaziello MC; Ilie M; Lassalle S; Butori C; Lerda N; Selva E; Gavric-Tanga V; Castillo L; Guevara N; Santini J; Pop D; Vénissac N; Mouroux J; Chabannon C; Hofman P
Ann Pathol; 2010 Oct; 30(5):337-43. PubMed ID: 21055520
[TBL] [Abstract][Full Text] [Related]
9. Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.
Pukkala E; Andersen A; Berglund G; Gislefoss R; Gudnason V; Hallmans G; Jellum E; Jousilahti P; Knekt P; Koskela P; Kyyrönen PP; Lenner P; Luostarinen T; Löve A; Ogmundsdóttir H; Stattin P; Tenkanen L; Tryggvadóttir L; Virtamo J; Wadell G; Widell A; Lehtinen M; Dillner J
Acta Oncol; 2007; 46(3):286-307. PubMed ID: 17450464
[TBL] [Abstract][Full Text] [Related]
10. Adolescent urologic oncology: current issues and future directions.
Cost NG; Cost CR; Geller JI; Defoor WR
Urol Oncol; 2014 Feb; 32(2):59-69. PubMed ID: 23141778
[TBL] [Abstract][Full Text] [Related]
11. Predicting intention to biobank: a national survey.
Critchley CR; Nicol D; Otlowski MF; Stranger MJ
Eur J Public Health; 2012 Feb; 22(1):139-44. PubMed ID: 20926403
[TBL] [Abstract][Full Text] [Related]
12. [Experience with establishment and operation of a biobank].
Stege A; Hummel M
Pathologe; 2008 Nov; 29 Suppl 2():214-7. PubMed ID: 18712392
[TBL] [Abstract][Full Text] [Related]
13. Nordic biological specimen bank cohorts as basis for studies of cancer causes and control: quality control tools for study cohorts with more than two million sample donors and 130,000 prospective cancers.
Pukkala E
Methods Mol Biol; 2011; 675():61-112. PubMed ID: 20949384
[TBL] [Abstract][Full Text] [Related]
14. A multidisciplinary approach to the management of urologic malignancies: does it influence diagnostic and treatment decisions?
Kurpad R; Kim W; Rathmell WK; Godley P; Whang Y; Fielding J; Smith L; Pettiford A; Schultz H; Nielsen M; Wallen EM; Pruthi RS
Urol Oncol; 2011; 29(4):378-82. PubMed ID: 19576797
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the research sample collections of Uppsala biobank.
Engelmark MT; Beskow AH
Biopreserv Biobank; 2014 Oct; 12(5):325-31. PubMed ID: 25340941
[TBL] [Abstract][Full Text] [Related]
16. [Perception by cancer patients of biomedical research in the era of large-scale biobanking].
Mancini J; Chabannon C; Vey N; Billard-Daufresne LM; Pellegrini I; Julian-Reynier C
Med Sci (Paris); 2012 Mar; 28 Spec No 1():28-32. PubMed ID: 22494654
[TBL] [Abstract][Full Text] [Related]
17. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
Allen D; Rixson L
Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
[TBL] [Abstract][Full Text] [Related]
18. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
[TBL] [Abstract][Full Text] [Related]
19. Cancer donor preferences for disposition of their biospecimens after biobank closure.
Allen SC; Dixon MD; Switchenko JM; Pentz RD
Cancer; 2017 Dec; 123(23):4648-4652. PubMed ID: 28746751
[TBL] [Abstract][Full Text] [Related]
20. [The haematological biobank--an infrastructure for quality assurance, development and research].
Johnsen HE; Pilgaard L; Højfeldt AD; Andersson TL; Schmitz A; Gade KH; Fogd K; Nyegaard M; Bøgsted M; Dybkær K
Ugeskr Laeger; 2011 May; 173(21):1489-93. PubMed ID: 21627910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
